Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Return on Capital Employed (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Return on Capital Employed for 12 consecutive years, with 0.01% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 14.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, up 14.0% year-over-year, with the annual reading at 0.01% for FY2025, 13.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.01% at Theravance Biopharma, up from 0.09% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.01% in Q4 2025, with the low at 0.92% in Q1 2021.
  • Average Return on Capital Employed over 5 years is 0.33%, with a median of 0.15% recorded in 2023.
  • The sharpest move saw Return on Capital Employed crashed -31bps in 2021, then skyrocketed 64bps in 2022.
  • Over 5 years, Return on Capital Employed stood at 0.78% in 2021, then surged by 82bps to 0.14% in 2022, then decreased by -7bps to 0.15% in 2023, then rose by 3bps to 0.15% in 2024, then skyrocketed by 94bps to 0.01% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.01%, 0.09%, and 0.11% for Q4 2025, Q3 2025, and Q2 2025 respectively.